Fellow Researchers Profile

Isao KAMAE

Isao KAMAE

Research Director

Project Professor, Health Technology Assessment and Public Policy, Graduate School of Public Policy, The University of Tokyo
Research Director, Musashino Institute for Global Affairs
President, ISPOR (Professional Society for Healtheconomics and Outcomes Research)

[Research Themes]
Institutionalization of the Health Technology Assessment system: Agenda and challenges from an international perspective

Expertise

  • Health Policy and Technology Assessment

Profile

Education

1995 Harvard University, Doctor of Public Health in health decision sciences
1988 Harvard School of Public Health, Master in Biostatistics
1985 Kobe University School of Medicine, M.D.
1979 Kyoto University, M.S., Information Science

Career

2018 Research Director, Musashino University Institute for Global Affairs
2012 Project Professor, Health Technology Assessment and Public Policy, Graduate School of Public Policy, The University of Tokyo
2012-2017 Adjunct Professor, Meiji Institute for Global Affairs
2011 Research Director, The Canon Institute for Global Studies
2007 Professor, Graduate School of Health Management, Keio University
1997 Professor, Recearch Center for Urban Safety and Security, Kobe University, and Professor, Medical Statistics, Kobe University Graduate School of Medicine
1994 Associate Professor, General Medicine and Clinical Epidemiology, Kyoto University Hospital
1993 Associate Professor, Medical Informatics, Shimane Medical University

Papers

  • Kamae I: Trial Implementation of Quasi Value-based Pricing for Pharmaceuticals and Medical Devices in Japan: Issues in Dispute. Revue Française des Affaires Sociales (RFAS), 3:223-244, 2018.
  • Mahlich J, Kamae I, Sruamsiri R: Pharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment. Expert Review of Pharmacoeconomics & Outcomes Research (Published online: 03 Nov 2017), DOI: 10.1080/14737167.2018.1394187
  • Marlich J, Kamae I, Rossi B: A New Health Technology Assessment System for JAPAN? Simulating the Potential Impact on the Price of Simeprevir. IJHTAHC 33:1, 2017